In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
GRAFFINITY AND RIGEL ENTER INTO DRUG DISCOVERY RESEARCH ALLIANCE
Rigel secures Hepatitis C virus license agreement from Chiron Corporation
Rigel gains rights to antiviral drug research technology
Rigel Pharmaceuticals and Pyxis Discovery start lead discovery collaboration
Genomic Solutions to acquire GeneMachines
The Institute for Genomic Research licenses microarray technology
Rigel and Novartis initiate second drug discovery collaboration
Cetek Extends Genomic Screening Agreement With SPRI